George L. Sing
Independent DirectorMr. George L. Sing is Co-Founder and Chairman of GanD, Inc. and has been its Chief Executive Officer since 2016. He serves as the Chairman of Grace Science, LLC. He was a Co-Founder and Managing Director at Lancet Capital since 1998. He was Co-Founder, Executive Chairman of Stentor, Inc. Mr. Sing was Co-Founder of Stemnion, Inc. (currently known as Noveome Biotherapeutics, Inc.) and served as its Chief Executive Officer from January 2004 to April 2015. From 1993 to 1998, he was a General Partner at Zitan Capital Partners. He was also a co-founding Senior Partner of two other venture capital firms, Advanced Technology Ventures and Merrill Lynch Ventures, where he pioneered initial investments in European and Asian venture funds. From February 1990 until February 1991, Mr. Sing was Co-Founder and Consultant at Merrill Lynch Venture Capital Inc. From 1982 to February 1990, he served as a Vice President and Member of the Board of Directors of Merrill Lynch Venture Capital, Inc. He serves as a Director of Lancet Capital. He has been an Independent Director at Regeneron Pharmaceuticals, inc. since January 01, 1988. Mr. Sing has been a venture capital investor for over 20 years, including co-founding seed stage startups in healthcare and high technology. He received Master of Business Administration degree from Harvard Business School and Bachelor of Engineering degree from Stevens Institute of Technology.
Positions
- Company NameRegeneron Pharmaceuticals, Inc.Stock CodeREGNPositionIndependent DirectorColleagues
- LSLeonard S. SchleiferCo-Founder, President, CEO & Co-Chairman
- GDGeorge D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman
- CRChristopher R. FenimoreExecutive VP of Finance & CFO
- JJJoseph J. LaRosaExecutive VP, General Counsel & Secretary
- AJAndrew J. MurphyExecutive VP of Research & Co-Chief Scientific Officer
- CAChristine Ann PoonLead Independent Director
- JLJoseph L. GoldsteinIndependent Director
